Capricor Therapeutics Tokenized Stock (Ondo) PriceCAPRON

What is Capricor Therapeutics Tokenized Stock (Ondo) (CAPRON)?

Capricor Therapeutics Tokenized Stock (Ondo) (CAPRON) is a tokenized equity product issued through the Ondo tokenized asset platform. It provides tokenholders with economic exposure similar to holding shares of Capricor Therapeutics, Inc. (NASDAQ: CAPR). Any dividends paid on the underlying shares would be reflected in the token's value; no dividends are currently paid. The token is issued across multiple chains, including Solana, Ethereum and BNB Chain. CAPRON enables non-US retail and institutional users to mint and redeem tokenized U.S. stocks and ETFs 24 hours a day, five days a week, with access to traditional exchange liquidity. The product is not issued, sponsored, endorsed, or affiliated with Capricor Therapeutics itself. Circulating supply is 262 CAPRon (total supply 262; no maximum supply).

Key Specifications & Tokenomics

• Name: Capricor Therapeutics Tokenized Stock (Ondo)
• Ticker / Symbol: CAPRON
• Blockchain: Multi-chain — deployed on Solana (primary listing), Ethereum and BNB Chain
• Contract Address: Solana: BS8zoc6pmALQnBhBDFak6eFhgGHjpebnHzsxApgondo; Ethereum: 0x70Ec0f5B23404C0cD6f29ce88f4af00A0b0d895D; BNB Chain: 0x812Fc2943371C952c6c8Daf99Fe665Eb0e40Cd27
• Contract Creation Date: 2026-03-09; CMC Listing Date: 2026-03-24
• Explorer: etherscan.io
• Categories: Tokenized Assets; Tokenized Stocks; Real World Assets (RWA); Ondo Tokenized Assets; Ethereum Ecosystem; Solana Ecosystem; BNB Chain Ecosystem
• ISIN: XFC000397368
• Website: app.ondo.finance
• Underlying Company: Capricor Therapeutics, Inc. (NASDAQ: CAPR)
• Dividends: None currently paid
• Maximum Supply: None fixed. As a tokenized equity product, CAPRon supply expands or contracts with minting and redemption demand on the Ondo platform; current total supply is 262 CAPRon.

Contract addresses and supply figures per CoinMarketCap registry data and Etherscan; product details per app.ondo.finance.

Who created Capricor Therapeutics Tokenized Stock (Ondo)?

CAPRON is issued through the Ondo tokenized asset platform, which specializes in bringing traditional financial instruments such as U.S. stocks and ETFs on-chain. The underlying company, Capricor Therapeutics, Inc., is a biotechnology firm listed on the Nasdaq Global Select Market under the ticker CAPR. Capricor Therapeutics is a biotechnology company developing therapies for Duchenne muscular dystrophy and beyond, with a multi-stage pipeline exploring allogeneic cardiosphere-derived cells (CDCs) and exosome science. Dr. Marbán serves as Chief Executive Officer and has held that position and a Board seat since November 2013; he is also a co-founder of Capricor. The token is issued by the Ondo tokenized asset platform (app.ondo.finance); the underlying equity issuer, Capricor Therapeutics, Inc., is not involved in issuing, sponsoring or endorsing the token.

How does Capricor Therapeutics Tokenized Stock (Ondo) work?

CAPRON functions as a tokenized representation of economic exposure to Capricor Therapeutics stock. Users can mint and redeem the tokenized asset through the Ondo platform, with the process designed to mirror the price performance of the underlying NASDAQ-listed equity. The token operates on Ethereum, leveraging its smart-contract infrastructure for issuance, transfer, and settlement. Secondary-market trading runs continuously, while minting and redemption against traditional exchange liquidity operate 24 hours a day, five days a week. The token is subject to additional restrictions and is intended for non-US retail and institutional users.

What makes Capricor Therapeutics Tokenized Stock (Ondo) unique and valuable?

CAPRON's primary distinction lies in bridging traditional equity markets with blockchain-based settlement. By tokenizing a Nasdaq-listed biotechnology stock, it offers global users exposure to Capricor Therapeutics without requiring direct access to U.S. brokerage infrastructure. The product provides continuous price discovery and trading availability beyond standard market hours. It integrates with the broader Ondo ecosystem of tokenized assets, allowing conversions between CAPRON and other Ondo tokenized instruments such as CLOAon, HIVEon, and CAMTon. This interoperability, combined with Ethereum's established security model, positions CAPRON as part of the growing real-world asset tokenization sector.

What is Capricor Therapeutics Tokenized Stock (Ondo) used for?

CAPRON is used to gain economic exposure to Capricor Therapeutics, Inc. stock in tokenized form. It allows eligible non-US users to hold and transfer a blockchain-based instrument that tracks the underlying equity. The token can be traded on supported venues, used in conversion pairs within the Ondo tokenized asset ecosystem, and held in compatible Ethereum wallets. It serves as a tool for portfolio diversification into biotechnology exposure and for participating in the tokenized stocks and real-world assets narrative. The product is not intended for US persons and carries additional restrictions.

How Is the Capricor Therapeutics Tokenized Stock (Ondo) ecosystem developing?

The ecosystem around CAPRON is tied to the expansion of Ondo's tokenized asset platform, which continues to add tokenized stocks and ETFs across multiple blockchain categories, including Ethereum, Solana, and BNB Chain. CAPRON is referenced across numerous tracking platforms, converters, and data aggregators, indicating growing integration within the broader tokenized asset infrastructure. The underlying company, Capricor Therapeutics, remains active in clinical development, with its Deramiocel BLA under FDA review and ongoing work with the regulatory agency. On 24 August 2026 Capricor announced an extension of the PDUFA target action date while the FDA continues its review of the Deramiocel BLA, and on 5 October 2026 it presented HOPE-3 open-label extension data on upper limb function in Duchenne muscular dystrophy at the 2026 World Muscle Society Congress. Developments in the underlying equity, such as FDA decisions and clinical data presentations, can influence interest in the tokenized product.

How are CAPRon tokens created and obtained?

CAPRon is not mined. New tokens are minted on the Ondo platform against the underlying equity and redeemed back through the same platform; users obtain CAPRon by minting through Ondo or buying on supported venues. Holding CAPRon generates no staking rewards or yield.

How to keep your Capricor Therapeutics Tokenized Stock (Ondo) Coin safe?

Store CAPRON in a reputable Ethereum-compatible wallet and safeguard your private keys or seed phrase offline. Because the token exists on Ethereum, standard security practices apply: verify the contract address 0x70ec0f5b23404c0cd6f29ce88f4af00a0b0d895d before interacting, avoid sharing sensitive wallet information, and use hardware wallets for larger holdings. No public audit report for this tokenized asset has been identified; verify the contract address 0x70ec0f5b23404c0cd6f29ce88f4af00a0b0d895d on Etherscan before interacting and treat tokenized-equity products as carrying issuer, custody and liquidity risk. Always conduct independent due diligence and understand the additional restrictions that apply to tokenized stock products before acquiring or holding CAPRON.